Literature DB >> 22095238

An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.

I Vermeulen1, I Weets, O Costa, M Asanghanwa, K Verhaeghen, K Decochez, J Ruige, K Casteels, J Wenzlau, J C Hutton, D G Pipeleers, F K Gorus.   

Abstract

AIMS/HYPOTHESIS: The appearance of autoantibodies (Abs) before diabetes onset has mainly been studied in young children. However, most patients develop type 1 diabetes after the age of 15 years. In first-degree relatives aged under 40 years, we investigated the frequency of seroconversion to (persistent) Ab positivity, progression to diabetes and baseline characteristics of seroconverters according to age.
METHODS: Abs against insulin (IAA), glutamate decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured during follow-up of 7,170 first-degree relatives.
RESULTS: We identified 379 (5.3%) relatives with positivity for IAA, GADA, IA-2A and/or ZnT8A (Ab(+)) at first sampling and 224 (3.1%) at a later time point. Most seroconversions occurred after the age of 10 years (63%). During follow-up, Abs persisted more often in relatives initially Ab(+) (76%) than in seroconverters (53%; p < 0.001). In both groups diabetes developed at a similar pace and almost exclusively with Ab persistence (136 of 139 prediabetic individuals). For both groups, progression was more rapid if Abs appeared before the age of 10 years. Baseline characteristics at seroconversion did not vary significantly according to age. CONCLUSIONS/
INTERPRETATION: Seroconversion to (persistent) Ab(+) occurs regardless of age. Although the progression rate to diabetes is higher under age 10 years, later seroconverters (up to age 40 years) have similar characteristics when compared with age-matched initially Ab(+) relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment in prevention trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095238      PMCID: PMC3810367          DOI: 10.1007/s00125-011-2376-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  38 in total

Review 1.  Prospects for predicting and stopping the development of type 1 of diabetes.

Authors:  F K Gorus; D G Pipeleers
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-09       Impact factor: 4.690

2.  Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies.

Authors:  Bart J Van der Auwera; Frans C Schuit; Ilse Weets; Ann Ivens; Jan E Van Autreve; Frans K Gorus
Journal:  Hum Immunol       Date:  2002-01       Impact factor: 2.850

3.  Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation.

Authors:  Carlotta von Berghes; Georg Brabant; Heike Biebermann; Heiko Krude; Susanna Wiegand
Journal:  Pediatr Diabetes       Date:  2011-03-29       Impact factor: 4.866

4.  IA-2 autoantibodies predict impending type I diabetes in siblings of patients.

Authors:  K Decochez; I H De Leeuw; B Keymeulen; C Mathieu; R Rottiers; I Weets; E Vandemeulebroucke; I Truyen; L Kaufman; F C Schuit; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2002-11-12       Impact factor: 10.122

5.  Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population-based study.

Authors:  K Savola; E Läärä; P Vähäsalo; P Kulmala; H K Akerblom; M Knip
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

6.  Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.

Authors:  P Achenbach; V Lampasona; U Landherr; K Koczwara; S Krause; H Grallert; C Winkler; M Pflüger; T Illig; E Bonifacio; A G Ziegler
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

7.  The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.

Authors:  T Kimpimäki; A Kupila; A M Hämäläinen; M Kukko; P Kulmala; K Savola; T Simell; P Keskinen; J Ilonen; O Simell; M Knip
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

Review 8.  Novel antigens in type 1 diabetes: the importance of ZnT8.

Authors:  Janet M Wenzlau; Lisa M Frisch; Thomas J Gardner; Suparna Sarkar; John C Hutton; Howard W Davidson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

9.  Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.

Authors:  Jay S Skyler; Camillo Ricordi
Journal:  Diabetes       Date:  2011-01       Impact factor: 9.461

10.  The Environmental Determinants of Diabetes in the Young (TEDDY) Study.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 6.499

View more
  12 in total

1.  Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescence.

Authors:  A J K Williams; P J Bingley
Journal:  Diabetologia       Date:  2012-05-20       Impact factor: 10.122

2.  Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient.

Authors:  D Jacobs-Tulleneers-Thevissen; M Chintinne; Z Ling; P Gillard; L Schoonjans; G Delvaux; B L Strand; F Gorus; B Keymeulen; D Pipeleers
Journal:  Diabetologia       Date:  2013-04-26       Impact factor: 10.122

3.  In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.

Authors:  E Mbunwe; B J Van der Auwera; I Weets; P Van Crombrugge; L Crenier; M Coeckelberghs; N Seret; K Decochez; E Vandemeulebroucke; P Gillard; B Keymeulen; C van Schravendijk; J M Wenzlau; J C Hutton; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2013-05-28       Impact factor: 10.122

4.  Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.

Authors:  F K Gorus; E V Balti; I Vermeulen; S Demeester; A Van Dalem; O Costa; H Dorchy; S Tenoutasse; T Mouraux; C De Block; P Gillard; K Decochez; J M Wenzlau; J C Hutton; D G Pipeleers; I Weets
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

5.  HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Authors:  Eric Mbunwe; Bart J Van der Auwera; Ilse Vermeulen; Simke Demeester; Annelien Van Dalem; Eric V Balti; Sara Van Aken; Luc Derdelinckx; Harry Dorchy; Jean De Schepper; Chris van Schravendijk; Janet M Wenzlau; John C Hutton; Daniël Pipeleers; Ilse Weets; Frans K Gorus
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

Review 6.  The Genetic Architecture of Type 1 Diabetes.

Authors:  Samuel T Jerram; Richard David Leslie
Journal:  Genes (Basel)       Date:  2017-08-22       Impact factor: 4.096

7.  Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study.

Authors:  Elin Pettersen Sørgjerd; Per M Thorsby; Peter A Torjesen; Frank Skorpen; Kirsti Kvaløy; Valdemar Grill
Journal:  BMJ Open Diabetes Res Care       Date:  2015-06-25

8.  The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design.

Authors:  Katrien Benhalima; Paul Van Crombrugge; Johan Verhaeghe; Sofie Vandeginste; Hilde Verlaenen; Chris Vercammen; Els Dufraimont; Christophe De Block; Yves Jacquemyn; Farah Mekahli; Katrien De Clippel; Roland Devlieger; Chantal Mathieu
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-11       Impact factor: 3.007

9.  The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.

Authors:  Polly J Bingley; David C Boulware; Jeffrey P Krischer
Journal:  Diabetologia       Date:  2015-12-16       Impact factor: 10.122

10.  Autoimmunity plays a role in the onset of diabetes after 40 years of age.

Authors:  Olov Rolandsson; Christiane S Hampe; Stephen J Sharp; Eva Ardanaz; Heiner Boeing; Guy Fagherazzi; Francesca Romana Mancini; Peter M Nilsson; Kim Overvad; Maria-Dolores Chirlaque; Miren Dorronsoro; Marc J Gunter; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Vittorio Krogh; Tilman Kühn; Domenico Palli; Salvatore Panico; Carlotta Sacerdote; Maria-José Sánchez; Gianluca Severi; Annemieke M W Spijkerman; Rosario Tumino; Yvonne T van der Schouw; Elio Riboli; Nita G Forouhi; Claudia Langenberg; Nicholas J Wareham
Journal:  Diabetologia       Date:  2019-11-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.